Cat cortical arterioles and venules were ex posed ill vivo to the Ca 2 + antagonist nifedipine under A presentation of the preliminary results of this study was given at the Satellite Abbreviations used: 5-HT, 5-Hydroxytryptamine; MCA, mid dle cerebral artery.
normal conditions and in focal ischemia. Topical applica tion of nifedipine caused a marked, concentration dependent arteriolar dilatation. The dilatatory responses increased significantly with decreasing arteriolar size. Peri venular microapplication of nifedipine invariably caused dilatation that was less pronounced but more long-lasting than that on the arteriolar side. Arterioles, The Ca2+ antagonIstic drug nifedipine induces relaxation of both isolated cerebral vessels in vitro (Allen and Banghart, 1979; Edvinsson et al., 1979) and feline cerebral arterioles in vivo after topical application . The present study was designed to investigate in more detail the vas cular responses of both the arteriolar and venular parts of the normal cortical pial microvasculature in vivo. It has been demonstrated that topical applica tion of nifedipine induces relaxation of feline cere bral arterioles in situ that had been previously con stricted by perivascular blood or cerebrospinal fluid (CSF) from patients with 44 which constricted after middle cerebral artery occlusion, invariably dilated following nifedipine application. These dilatatory responses were transient but could be repeated, and on some occasions were accompanied by a return of flow in vessels in which stasis had been present. The results suggest that nifedipine is able to dilate cerebral vessels both under normal conditions and when con tracted during focal ischemia. Key Words: Calcium antagonist-Dilatation-Focal ischemia-Nifedipine.
aneurysmal subarachnoid hemorrhage (Brandt et al., 198 1) . In the present study, we have also deter mined whether topical application of nifedipine could reverse the delayed arteriolar constriction that can occur under other pathological cir cumstances, namely, focal cerebral ischemia (Teas dale et al. , 198 1) .
METHODS
The experiments were performed on 17 cats of both sexes. After induction of anaesthesia with intravenous Saffan® (alpha-xolone, 6.75 mg/kg, and alpha-dolone acetate, 2.25 mg/kg body weight) and maintenance by alpha-chloralose (60 mg/kg), the intubated animals were ventilated with a respiratory pump at a rate and volume adjusted to maintain normoxia and normocapnia. End tidal Pcoz and blood pressure were continuously moni tored. Arterial blood samples were frequently checked for Pac02, Pao2, pH, and base deficit. Any base deficit was corrected with sodium bicarbonate given by slow intrave nous infusion. Body temperature was kept at 37 ± 0.5°C.
A left-sided craniectomy (3 x 2 cm) was performed with the head fixed in a stereotaxic frame and the dura reflected. The exposed gyri were irrigated continuously with mineral oil maintained at a temperature of 37°C.
Pial vessel caliber was measured by a television
image-splitting technique (MacKenzie et aI., 1976) .
Perivascular microinjections were made using mi cropipettes with a tip diameter of approximately 8 fLm. To minimize any change in the pH of the solutions in the pipettes, the tops were sealed with mineral oil and the tips submerged in the bulk of the solution and sealed under oil (Harper and MacKenzie, 1977) . A hydraulic syringe was used to inject approximately 2 fLl of the solution into the perivascular space.
Nifedipine (obtained from Bayer AG), dissolved in ethanol, polyethylene glycol, and water, was further di luted in a mock CSF solution. 1 The final pH of the solu tion was 7.18. Nifedipine, in five different concentrations (0.02, 0.2, 2.0, 20.0, and 40.0 fLg/ml), was applied to the arterioles; the venules were exposed to the 20.0-fLg/ml concentration. Test solutions containing the ethanol and polyethylene glycol vehicle corresponding to the different nifedipine solutions were prepared. To prevent decompo sition of nifedipine, the solutions were protected from light exposure except during perivascular injections.
Focal ischemia in the parietal cortex was induced by clamping the left middle cerebral artery (MCA) through a transorbital exposure. For description of pial vessel caliber changes following MCA occlusion see .
RESULTS
The resting diameters of the arterioles studied were in the range of 34 to 246 fLm, and of the ven ules, 41 to 216 fLm. All perivascular microinjections were performed at normocapnia (5. 1 ± 0.5 kPa) and normotension (116. 1 ± 7.3 mm Hg) (mean ± SD).
Arteriolar responses
Topical application of nifedipine caused a con centration-dependent arteriolar dilatation (Fig. 1 ). The dilatatory responses were prompt, with peak values mostly reached within 90 s. The dilatatory response increased significantly (p < 0.00 1) with decreasing arteriolar size. The individual dilatatory responses to one nifedipine concentration (20 fLg/ml) are shown in Fig. 2 . The linear regressions of the dilatatory responses to each nifedipine con centration are given in Fig. 3 . The arterioles re turned to resting diameter within 10-15 min after the nifedipine applications.
The arteriolar dilatatory responses to vehicle solutions corresponding to 20.0 and 40.0 fLg/ml nifedipine solutions are illustrated in Fig. 4 . As shown, mock CSF elicited a slight and transient dilatatory response that closely resembles that after application of the vehicle solution corresponding to 1 Mock CSF had the following composition: Na+, 156 mM; K', 3 mM; Ca2+, 1. 5 mM; C1-, 151 mM; and HC03-, 11 mM. 20.0 fLg/ml nifedipine. In contrast, after applica tion of the vehicle solution corresponding to 40.0 fLg/ml nifedipine, the dilatation was slower in onset but longer in duration and more pronounced.
Venular responses
The application of nifedipine around 16 venules invariably resulted in a dilatation, which ranged from 16.2 to 47.9% (mean value, 26. 1%). The re sponses of these veins were less pronounced than those of arterioles of comparable size (Fig. 5 ). When compared with the effect of vehicle solution on veins ( Fig. 6) , nifedipine resulted in a more gradual onset, building up over 2-6 min, and more persistent. Maximal nifedipine-induced dilatatory responses were 26 ± 4%, compared to maximal vehicle-induced dilatatory responses of 15 ± 2%. The venules returned to pre-injection diameter within approximately 15 min after vehicle injec tions, whereas after nifedipine, the effect persisted for 20 min (Fig. 6 ). Resting Calibre fJm
Arteriolar responses in ischemic cortex
After MCA occlusion, all pial arterioles showed a dilatation that first became apparent 15 -30 s after occlusion. All vessels in the anterolateral gyrus showed sustained dilatation, whereas delayed con striction occurred in the suprasylvian gyrus and most frequently in the ectosylvian gyrus 2-9 min after occlusion (Teasdale et aI. , 198 1) .
When 20.0 ILg/ml of nifedipine was injected around the arterioles that had become constricted, there was invariably a marked arteriolar dilatatory response (Fig. 7) . These dilatatory responses were transient but could be repeated (Fig. 7) , and, on some occasions, were accompanied by a return of flow in vessels in which stasis had been present. (Fig. 8) . 
DISCUSSION
Smooth muscle tone is thought to be maintained by release of intracellular calcium (Ruegg, 1971) . Calcium initiates contraction by activating the en zyme myosin -light-chain kinase that causes phos phorylation of myosin, which is necessary for its interaction with actin (Small and Sobleszek, 1977) . Golenhofen and Hermstein (1973) have suggested the existence of two main types of calcium dependent activation mechanisms in smooth mus cle: one correlated to spike discharges and respon sible for phasic activation (P-mechanism) and the other correlated to a spike-free depolarization and responsible for tonic activation (T-mechanism).
It cannot be excluded that calcium influx during these types of activation occurs through separate channels in the membrane (Bolton, 1979) . Accord ing to Fleckenstein (1977) , calcium antagonistic drugs selectively inhibit the calcium influx into the cell and the main site of their action is the slow channels in the membrane. Different calcium an tagonists are said to block the P-mechanism more or less selectively, D600 and nifedipine showing the highest selectivity (Golenhofen and Hermstein, 1975) . These drugs also selectively block the voltage-sensitive calcium channels possibly as sociated with phasic activation (Bolton, 1979) .
The present study clearly demonstrates that nifedipine, when locally applied around cat pial ves sels in situ, results in a consistent dose-related di latation. The consistent pattern of increasing di latatory responses with decreasing vessel size, ex pressed as percentage vessel diameter change from resting vessel caliber, is in agreement with the ob servations of Betz and Csornai (1978) , who per formed microperfusions of the perivascular space in cats with a calcium-free mock CSF also containing ethyleneglycol bis(aminoethylether)tetraacetate (EGTA). A possible explanation for the increasing arteriolar reaction with decreasing vessel diameter might be that the tone of small arterioles is not only higher, but also more dependent on extracellular calcium, thus making smaller vessels more sensitive to a blockade of accessible extracellular calcium ions. This in turn suggests that the phasic activation (P-mechanism) is of greater importance than the tonic activation (T-mechanism) in the smaller ves- In the present study, a step-wise increase in the concentrations of the applied nifedipine solutions caused a corresponding step-wise increase in di latatory response. However, increasing the nifedipine concentration from 20.0 to 40.0 fLg/ml caused an unexpected exaggeration of the dilatatory response. As illustrated in Fig. 4 , the vehicle, in a concentration corresponding to that used with 20.0 fLg/ml nifedipine, caused only a small and transient dilatatory response, whereas that of a concentration corresponding to the 40.0 fLg/ml nifedipine solution induced a much more pronounced and also more long-lasting dilatatory response. Hence, the very pronounced dilatatory effect of the 40.0-fLg/ml solu tion might represent the combined effects of the drug and vehicle.
The dilatatory responses to nifedipine reached the maximum within approximately 60 s and were invariably more long-lasting (> 10 min) than those observed by other investigators following peri vas- cular application of 5-hydroxytryptamine (5-HT, serotonin) to cat pial arterioles with a resting caliber of <70 fLm. The duration of the 5-HT effects were less than 120 s (Harper and MacKenzie, 1977) , probably reflecting effective mechanisms in activa tion or elimination of the amine. The more long lasting effect of nifedipine might be due to its high lipid solubility slowing its removal from the vessel wall.
Microapplication of the mock CSF invariably caused a minor and transient dilatation, which is in agreement with the results of other investigators using the same model but with spinal pial vessels (Crawford et aI., 1980) .
The dilatatory effect of nifedipine on the venular part of the pial microvasculature indicates that ce rebral venules have a tone that is dependent on ex tracellular calcium. The observation that the venu lar dilatatory responses were less pronounced than the arteriolar responses could probably be ex- plained by less elasticity of the venular wall and/or a lower intravascular pressure. A striking difference in the time-course between venular dilatations and arteriolar dilatations was observed. This difference does not favour the concept that venular dilatations are simply due to a passive pressure effect, because of increased blood flow secondary to dilatations of adjacent arterioles. The difference in the dilatatory responses be tween arterioles and venules is illustrated in Fig. 5 , 1 which also shows the differences in responses to the vehicle alone. Although the maximum responses to the nifedipine and vehicle solutions did not differ significantly on the venules, there was a striking difference in the time-course of the ensuing va sodilatation in the two types of induced dilatation, indicating different modes of action (Fig. 6 ).
In the series of experiments in which focal isch emia was produced and nifedipine was applied to arterioles showing delayed constriction, the con- striction was invariably and immediately reversed (Fig. 9 ). The resulting dilatation indicates that the mechanisms for the delayed ischemic arteriolar constriction are calcium-dependent. A comparison between mean arteriolar dilatatory responses to 20.0 lLg/ml nifedipine on normal vessels and con stricted vessels in focal ischemia is shown in Fig.  10 . In the "ischemic" arterioles, the amplitude of nifedipine-induced dilatations from maximum con striction level does not differ significantly from the amplitude of the dilatations of normal arterioles from resting vessel caliber. However, when maximum dilatation from resting vessel caliber of both groups is compared, an interesting difference between the ischemic vessels and normal vessels is apparent. If this difference is not a consequence of decreased intraluminal pressure in ischemic ar terioles, then the constrictions observed during ischemia seem to be elicited at least partly by mech anisms insensitive to calcium inhibitors of the nifedipine type. If nifedipine acts only by inhibiting calcium influx through membrane-potential-sensi tive calcium channels, the present findings indicate that arteriolar constriction during ischemia is partly caused by either influx of calcium through calcium channels of another type or release of calcium from intracellular stores. Church and Zsoter (1980) sug gested that nifedipine also has an intracellular site of action inhibiting the release of calcium. Whether such a mechanism is of importance for the relaxant effect shown in the present experiments is an open question.
